• No results found

ATTENDANCE APPLICATION

N/A
N/A
Protected

Academic year: 2022

Share "ATTENDANCE APPLICATION"

Copied!
1
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

9

th

International Forum for Clean Energy Technologies

SERBIAN ENERGY HORIZON 2020

Novi Sad, 29

th

– 30

th

September 2015

ATTENDANCE APPLICATION

First Name: Family

Name:

Company/Institution:

Position:

Address:

City, Zip Code &

Country:

Phone: Fax:

Mobile: E-mail:

Web address:

Attendance Application for Day(s):

29th September, 2015 YES / NO

30th September, 2015 YES / NO

Subject of your presentation (optional):

Application forms should be submitted latest until 10th of September, 2015 by e-mail: djakovic@uns.ac.rs

or fax: +381 (0) 21 635 0775

Department of Energy and Process Engineering Faculty of Technical Sciences, 21125 Novi Sad, Serbia

Referenties

GERELATEERDE DOCUMENTEN

Several articles in the Research Topic also focus on intervention aspects for youth with school attendance problems.. Maeda and Heyne report on a rapid return to school approach

• Level of compliance: past behaviour & intention • Understanding of competition

Obviously, this will entail a certain degree of error: (1) some people will participate, but not show up on the mobile phone data; (2) not all people that are present will

Whichever way non-attendance was defined (absent on any one day, total days absent and persistent absence), the same four factors were associated with higher levels of

After deliberation on the legality of women’s atten- dance at mosques for congregational prayers, the majority of jurists, both Sunni and Shi'ite, concluded that women

This research has some limitations, which form the starting point for recommendations for future research. Due to the qualitative research method the results are not

Maar tegelijkertijd wordt met een tweede leverancier (bijvoorbeeld degene die tweede is geworden in de aanbesteding) een contract gesloten dat vooralsnog geen

We aimed to identify the effect of patient participation on pharmacovigilance by exploring four main aspects, namely (i) information related to the nature of the reported adverse